You just read:

The U.S. Food & Drug Administration Approves Endari™ (L-glutamine oral powder), the First and Only Treatment for Sickle Cell Disease in Pediatric Patients and First in Nearly 20 Years for Adults

News provided by

Emmaus Life Sciences Inc.

Jul 07, 2017, 15:57 ET